Holen Sie sich die Stockscreener-App
8.54
0.12%
-0.01
Chimerix Inc Aktie (CMRX) Neueste Nachrichten
Former Chimerix CEO Andriole to lead Artios - biocentury.com
Jazz gets FDA okay for Chimerix brain cancer drug - pharmaphorum
Jazz Earnings: Xywav and Epidiolex Drive Growth; US Approval for Chimerix's Dordaviprone Promising - Morningstar
Chimerix buyout a win for Jazz with FDA nod for rare glioma drug - BioWorld MedTech
FDA approves targeted brain cancer drug from Jazz’s Chimerix buyout - Endpoints News
JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut - TradingView
Jazz Pharmaceuticals 2025 Q2 Earnings Misses Targets as Net Loss Surges 538% - AInvest
Chimerix’s ONC201 Study: A Potential Game-Changer in Glioma Treatment - TipRanks
Comparing BetterLife Pharma (OTCMKTS:PVOTF) & Chimerix (NASDAQ:CMRX) - Defense World
Chimerix, Inc. (NASDAQ:CMRX) Shares Purchased by Two Sigma Investments LP - Defense World
Squarepoint Ops LLC Makes New Investment in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Jane Street Group LLC Buys New Position in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Two Sigma Advisers LP Has $41,000 Stock Holdings in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
CHIMERIX Earnings Preview: Recent $CMRX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Northern Trust Corp Sells 36,038 Shares of Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Chimerix, Inc. (NASDAQ:CMRX) Shares Purchased by Millennium Management LLC - Defense World
Balyasny Asset Management L.P. Purchases Shares of 60,317 Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Chimerix (NASDAQ:CMRX) Now Covered by StockNews.com - Defense World
StockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX) - Defense World
Halper Sadeh LLP, bluebird bio, Inc., Walgreens Boots Alliance, Chimerix, Inc. - Olean Times Herald
Chimerix (NASDAQ:CMRX) Earns Sell Rating from Analysts at StockNews.com - Defense World
Chimerix, Inc. to Host Earnings Call - ACCESS Newswire
Why Chimerix Inc. (CMRX) is Surging in 2025 - Insider Monkey
Investor Network: Chimerix, Inc. to Host Earnings Call - ACCESS Newswire
Geode Capital Management LLC Lowers Stock Holdings in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Jazz Pharmaceuticals Acquires Chimerix for $935M - Contract Pharma
Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix - marketscreener.com
Jazz Pharmaceuticals acquires Chimerix for $935 million By Investing.com - Investing.com South Africa
Chimerix Terminates Loan and Delists from Nasdaq - TipRanks
Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ St - GuruFocus
Jazz Pharmaceuticals (JAZZ) Completes Acquisition of Chimerix - StreetInsider
Jazz Pharmaceuticals Completes Acquisition of Chimerix - TipRanks
Jazz Pharmaceuticals acquires Chimerix for $935 million - Investing.com
Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ Stock News - GuruFocus
Jazz's $935M Chimerix Buyout Targets First-Ever Treatment for Rare Brain Cancer, FDA Verdict Looms - Stock Titan
Jazz Pharmaceuticals' $935M Chimerix Deal: A Bold Move in Rare Oncology - AInvest
Chimerix stock soars to 52-week high, hits $8.54 By Investing.com - Investing.com South Africa
Chimerix stock soars to 52-week high, hits $8.54 - Investing.com
Unlocking Investment Potential Discover the Power of Magical Signals Bullish Signal - AInvest
Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
Chimerix stock soars to 52-week high, hits $8.53 By Investing.com - Investing.com Australia
Chimerix stock soars to 52-week high, hits $8.53 - Investing.com
Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - MSN
Jazz Pharmaceuticals, Chimerix HSR waiting period expired on March 31 - MLex
11 Best Performing NASDAQ Stocks So Far in 2025 - Insider Monkey
Exploring US High Growth Tech Stocks In March 2025 - simplywall.st
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):